Bioprinting, the production of tissue by 3D printing, is a rapidly emerging technology with high potential for tissue engineering also in cardiac surgery. The paper provides insight in currently available techniques, opportunities for application and perspectives of this revolution in medicine.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
August 18, 2014
Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial
August 16, 2014
In this multi-institution randomized trial, patients with heart failure underwent daily telemonitoring and standard care or just standard care. At 1 year, fewer patients in the telemonitoring group had worsened composite score (19% vs 27%) and experienced fewer deaths (10 vs 27 pts).
August 11, 2014
The authors of this study investigated the effect of myectomy on pulmonary hypertension in patients with hypertrophic cardiomyopathy (HCM).
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery
June 8, 2014
In this study, the authors identify a number of markers in cardiac stem cells obtained from 38 patients undergoing coronary artery bypass grafting which appear to predict positive myocardial remodelling at 12 months following surgery
Myectomy and mitral repair through the left atrium in hypertrophic obstructive cardiomyopathy: The preferred approach for contemporary surgical candidates?
May 21, 2014
The authors present results of surgery in 12 pts for hypertrophic cardiomyopathy extending to the papillary muscles. Repair was performed through a detached anterior mitral leaflet, which was subsequently repaired. The intraventricular end-diastolic gradient was decreased by 80% postop, and mitral regurgitation that was present preop was eliminated
May 7, 2014
Results of a 50 year experience with surgery for cortriatriatum sinister were summarized. A mix of infants and adults underwent treatment, consisting of membrane excision on CPB. 10 year survival was 83%, and all patients were in NYHA class I or II at follow-up.
March 10, 2014
This video shows a female toddler with diagnosed idiopathic dilated cardiomyopathy. The patient presented with worsening symptoms of congestive heart failure and was treated with the help of a left ventricular assist device.
Preoperative Atrial Fibrillation Increases Risk of Thromboembolic Events After Left Ventricular Assist Device Implantation
October 7, 2013
This study of 389 pts receiving a continuous flow LVAD evaluated the risk of thromoembolic (TE)complications associated with preop AF. TE occured in 25% of pts; freedom from TE at 2 years was 46% in those with AF and 72% in those without AF (p<0.001). AF did not affect late survival.
January 4, 2012
This article describes how a HeartMate XVE left ventricular assist device may be exchanged for a HeartMate II axial-flow pump with low morbidity and mortality and without a full sternotomy.
Ventricular Restoration for Akinesia (Modified Dor Procedure): Myocardial Protection and Surgical Approach
August 7, 2011
By C. L. Athanasuleas, MD and G. D. Buckberg, MD